Abstract
A First in Human Study Planned to Evaluate Hdp-101, an Anti-BCMA Amanitin Antibody-Drug Conjugate with a New Payload and a New Mode of Action, in Multiple Myeloma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have